Literature DB >> 22495393

Increase of circulating B7-H4-expressing CD68+ macrophage correlated with clinical stage of lung carcinomas.

Cheng Chen1, Yi-Bei Zhu, Yu Shen, Ye-Han Zhu, Xue-Guang Zhang, Jian-An Huang.   

Abstract

Tumor-associated macrophages (TAM) influence diverse processes such as angiogenesis, tumor cell proliferation, and metastasis during tumor progression. In a variety of tumor types, the amount of TAM has been associated with prognosis, but their role in lung cancer has not been fully elucidated. The purpose of this study was to investigate the B7-H4-expressing TAM in a series of 56 cases of lung carcinoma. In peripheral blood, B7-H4-expressing macrophage (CD68(+) cells) was compared among patients with lung cancer, patients with tuberculosis, and healthy donors. B7-H4-expressing macrophage in peripheral blood from lung cancer patients was significantly higher than that from healthy donors and tuberculosis patients. B7-H4-expressing macrophage was thereafter related to tumor size, lymph node metastasis and TNM stage. On the basis of the data obtained from literature, it is suggestd that lung carcinomas increase B7-H4-expressing macrophages, which might favor tumor progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22495393     DOI: 10.1097/CJI.0b013e31824212c4

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  14 in total

1.  The increase of circulating PD-L1-expressing CD68(+) macrophage in ovarian cancer.

Authors:  Qiu-Xia Qu; Qin Huang; Yu Shen; Yi-Bei Zhu; Xue-Guang Zhang
Journal:  Tumour Biol       Date:  2015-11-06

Review 2.  B7-H4 as a potential target for immunotherapy for gynecologic cancers: a closer look.

Authors:  Jenessa B Smith; Caitlin Stashwick; Daniel J Powell
Journal:  Gynecol Oncol       Date:  2014-03-20       Impact factor: 5.482

3.  Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphoma.

Authors:  Hideaki Nitta; Yasuhito Terui; Masahiro Yokoyama; Yuko Mishima; Noriko Nishimura; Kyoko Ueda; Yoshiharu Kusano; Naoko Tsuyama; Kengo Takeuchi; Yoshinobu Kanda; Kiyohiko Hatake
Journal:  Haematologica       Date:  2014-09-26       Impact factor: 9.941

4.  B7-H6 expression in non-small cell lung cancers.

Authors:  Xiuqin Zhang; Guangbo Zhang; Yan Qin; Ruizhen Bai; Jianan Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 5.  Inhibitory receptors as targets for cancer immunotherapy.

Authors:  Meghan E Turnis; Lawrence P Andrews; Dario A A Vignali
Journal:  Eur J Immunol       Date:  2015-07       Impact factor: 5.532

Review 6.  Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers.

Authors:  Irina Larionova; Gulnara Tuguzbaeva; Anastasia Ponomaryova; Marina Stakheyeva; Nadezhda Cherdyntseva; Valentin Pavlov; Evgeniy Choinzonov; Julia Kzhyshkowska
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

7.  A gene expression-based immune signature for lung adenocarcinoma prognosis.

Authors:  Lijuan Wang; Xizhi Luo; Chao Cheng; Christopher I Amos; Guoshuai Cai; Feifei Xiao
Journal:  Cancer Immunol Immunother       Date:  2020-05-05       Impact factor: 6.968

Review 8.  B7 family checkpoint regulators in immune regulation and disease.

Authors:  Sabrina Ceeraz; Elizabeth C Nowak; Randolph J Noelle
Journal:  Trends Immunol       Date:  2013-08-13       Impact factor: 16.687

Review 9.  Tumor-associated macrophages: from mechanisms to therapy.

Authors:  Roy Noy; Jeffrey W Pollard
Journal:  Immunity       Date:  2014-07-17       Impact factor: 31.745

10.  Tumour-associated macrophages correlate with microvascular bed extension in colorectal cancer patients.

Authors:  Ilaria Marech; Michele Ammendola; Rosario Sacco; Giuseppe Sammarco; Valeria Zuccalà; Nicola Zizzo; Christian Leporini; Maria Luposella; Rosa Patruno; Gianfranco Filippelli; Emilio Russo; Mariangela Porcelli; Cosmo Damiano Gadaleta; Giovambattista De Sarro; Girolamo Ranieri
Journal:  J Cell Mol Med       Date:  2016-04-22       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.